Antiplatelet therapy at the time of coronary artery bypass grafting: A multicentre cohort study

European Journal of Cardio-thoracic Surgery

Volumn 44, Issue 2, 2013, Pages

  Kremke, Michael ^a   Tang, Mariann ^a   Bak, Mikkel ^b   Kristensen, Katrine Lawaetz ^b   Hindsholm, Karsten ^c   Andreasen, Jan Jesper ^c   Hjortdal, Vibeke ^a   Jakobsen, Carl Johan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antiplatelet drugs; Aspirin; Bleeding; Blood transfusion; Clopidogrel; Coronary artery bypass

Indexed keywords

ACETYLSALICYLIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; CLOPIDOGREL; CREATININE; FRESH FROZEN PLASMA; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD TRANSFUSION; BODY MASS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHEST TUBE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DIALYSIS; DRUG USE; ENDOCARDITIS; ERYTHROCYTE TRANSFUSION; FEMALE; GENDER; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REOPERATION; RISK ASSESSMENT; SURGICAL MORTALITY; UNSTABLE ANGINA PECTORIS;

ANTIPLATELET DRUGS; ASPIRIN; BLEEDING; BLOOD TRANSFUSION; CLOPIDOGREL; CORONARY ARTERY BYPASS;

AGED; ANALYSIS OF VARIANCE; ASPIRIN; BLOOD TRANSFUSION; COHORT STUDIES; CORONARY ARTERY BYPASS; DENMARK; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; REOPERATION; THROMBOSIS; TICLOPIDINE;

EID: 84880680309     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt230     Document Type: Article

References (23)

1. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-21.
2. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
3. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK et al. Effects of pretreatment with clopidogrel and aspirin followed by longterm therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33.
4. Ebrahimi R, Dyke C, Mehran R, Manoukian SV, Feit F, Cox DA et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2009;53:1965-72.
5. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004;110:1202-8.
6. Chu MW, Wilson SR, Novick RJ, Stitt LW, Quantz MA. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004;78:1536-41.
7. Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. J Am Coll Cardiol 2008;52:1693-701.
8. Herman CR, Buth KJ, Kent BA, Hirsch GM. Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg 2010;89:397-402.
9. Ferraris VA, Ferraris SP, Saha SP, Hessel EA II, Haan CK, Royston BD et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 2007;83:27-86.
10. Fitchett D, Eikelboom J, Fremes S, Mazer D, Singh S, Bittira B et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Can J Cardiol 2009;25:683-9.
11. Dunning J, Versteegh M, Fabbri A, Pavie A, Kolh P, Lockowandt U et al. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008;34:73-92.
12. Schmidt M, Maeng M, Jakobsen CJ, Madsen M, Thuesen L, Nielsen PH et al. Existing data sources for clinical epidemiology: The Western Denmark Heart Registry. Clin Epidemiol 2010;2:137-44.
13. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
14. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 2007;49:1505-16.
15. Miceli A, Duggan SM, Aresu G, de Siena PM, Romeo F, Glauber M et al. Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 2013;43:722-8.
16. Bybee KA, Powell BD, Valeti U, Rosales AG, Kopecky SL, Mullany C et al. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005;112:I286-292.
17. Jacob M, Smedira N, Blackstone E, Williams S, Cho L. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. Circulation 2011;123: 577-83.
18. Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, Wilmer C et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288: 2411-20.
19. Nijjer SS, Watson G, Athanasiou T, Malik IS. Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. Eur Heart J 2011;32:2970-88.
20. Mehta RH, Roe MT, Mulgund J, Ohman EM, Cannon CP, Gibler WB et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 2006;48:281-6.
21. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57.
22. Varenhorst C, Alström U, Scirica BM, Hogue CW, Asenblad N, Storey RF et al. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol 2012;60:1623-30.
23. Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 2012;307:265-74.